Want to see HAE full AI Analyst Report?
Haemonetics (HAE) Ownership Overview
1.82% Insiders
38.40% Mutual Funds
24.14% Other Institutional Investors
28.25% ETFs
7.38% Public Companies and
Individual Investors
The ownership structure of Haemonetics (HAE) stock is a mix of institutional, retail, and individual investors. Approximately 90.79% of the company’s stock is owned by Institutional Investors, 1.82% is owned by Insiders, and 7.38% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 12, 2025 | xxxxxxxxxxxxx | $98784 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2026 | xxxxxxxxxxxxx | $2726528 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $320745 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $591780 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $360704 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,354,464 | Institution | 11.77% | 560,344,658 | |
| 4,251,151 | Institution | 9.34% | 444,882,952 | |
| 3,753,193 | Institution | 8.25% | 392,771,647 | |
| 3,719,710 | Institution | 8.18% | 389,267,652 | |
| 2,060,966 | Institution | 4.53% | 215,680,092 | |
| 1,067,581 | Institution | 2.35% | 111,722,352 | |
| 972,988 | Institution | 2.14% | 101,823,194 | |
| 865,250 | Institution | 1.90% | 90,548,413 | |
| 662,504 | Institution | 1.46% | 69,331,044 | |
| 643,711 | Institution | 1.41% | 67,364,356 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,753,193 | Institution | 8.25% | 392,771,647 | |
| 3,719,710 | Institution | 8.18% | 389,267,652 | |
| 972,988 | Institution | 2.14% | 101,823,194 | |
| 865,250 | Institution | 1.90% | 90,548,413 | |
| 640,201 | Institution | 1.41% | 66,997,035 | |
| 639,350 | Institution | 1.41% | 66,907,978 | |
| 612,960 | Institution | 1.35% | 64,146,264 | |
| 506,987 | Institution | 1.11% | 53,056,190 | |
| 363,531 | Institution | 0.80% | 38,043,519 | |
| 345,956 | Institution | 0.76% | 36,204,295 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,607,418 | Institution | 3.53% | 168,216,294 | |
| 1,567,099 | Institution | 3.44% | 121,152,424 | |
| 1,447,193 | Institution | 3.18% | 123,792,889 | |
| 1,213,003 | Institution | 2.67% | 126,940,764 | |
| 1,042,525 | Institution | 2.29% | 78,189,375 | |
| 535,269 | Institution | 1.18% | 45,786,910 | |
| 404,519 | Institution | 0.89% | 42,332,913 | |
| 339,647 | Institution | 0.75% | 35,544,059 | |
| 331,783 | Institution | 0.73% | 28,380,718 | |
| 301,974 | Institution | 0.66% | 25,830,856 |
FAQ
Who Owns Haemonetics (HAE)?
According to the latest TipRanks data, approximately 24.14% of the company's stock is held by institutional investors, 1.82% is held by insiders, and 7.38% is held by retail investors.
What percentage of Haemonetics (HAE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.14% of Haemonetics (HAE) stock is held by institutional investors.
What percentage of Haemonetics (HAE) stock is held by retail investors?
According to the latest TipRanks data, approximately 7.38% of Haemonetics (HAE) stock is held by retail investors.
Who owns the most shares of Haemonetics (HAE)?
iShares owns the most shares of Haemonetics (HAE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.